UPDATE: Deutsche Bank Upgrades Humana to Hold, Raises PT Following Ninth Annual Employer Health Benefits Survey

In a report published Tuesday, Deutsche Bank analyst Scott Fidel upgraded the rating on Humana HUM from Sell to Hold, and raised the price target from $115.00 to $140.00. In the report, Deutsche Bank noted, “We view valuations as reasonable for diversified MCOs relative to the market although these stocks have produced major gains the past few years which leave them exposed to enhanced volatility on downside surprises. We are upgrading our rating on ANTM to Buy from Hold since our survey data points to a stronger fundamental outlook for the company in 2015 than we previously expected. We are also upgrading our rating on Humana to Hold from Sell as we less downside in the stock price as we roll our price targets over to our 2016 EPS estimates although we still see above-average EPS risks.” Humana closed on Monday at $142.99.